Prevention of Bisphosphonate-Related Osteonecrosis of the Jaws in Patients with Prostate Cancer Treated with Zoledronic acid – a prospective study over 6 years

To explore the preventive effect of a prophylactic oral and maxillofacial treatment to reduce bisphosphonate associated necrosis of the jaws (BRONJ) in metastatic prostate cancer (PC) patients treated with zoledronic acid (4.0 mg i.v./months).

from #ENT via xlomafota13 on Inoreader http://ift.tt/2avsBYx
via IFTTT